It is a great honor for us to have completed this first funding round with our investors, Corallia Ventures  and Lars Rasmussen . We sincerely thank them for their trust and belief in our vision to develop innovative, tissue bioprinting–based solutions to address unmet medical needs and improve the quality of life for thousands of patients. https://lnkd.in/eRxJbMVN

We’re proud to announce that we’ve been selected to pitch our solution at Europe’s leading platform for HealthTech innovation and investment — the HealthTech Investor Summit, taking place 8–10 December 2025 in Utrecht. For three days, we’ll be joining innovators, investors, and industry experts to exchange ideas, explore partnerships, and unlock new funding opportunities. Read more

A big thank-you to PRAXI Network and Brookstreet Equity Partners LLP for the ConnectingTheDots initiative and for highlighting the strength of Greek innovation. At PhosPrint, we’re bringing Laser BioPrinting and regenerative medicine closer to the patient — providing research teams and tools for targeted tissue therapies. We’re proud of our progress and excited for the next steps in London on 14 November 2025. Many thanks to the organizers, judges, and community for their tru